A clinical formulation indicated for Skin Care. Combined medicinal properties work to regulate rapid skin cell proliferation and diminish inflammation, which promotes visible clearance of scaly skin patches.
Indicated to address plaque psoriasis by targeting skin cell turnover and inflammation to alleviate scaling and support smoother skin appearance in adult patients.
Mechanism of Action
Calcipotriol slows down the rapid growth of skin cells that cause scaling. Betamethasone reduces the swelling, redness, and itching associated with the psoriasis plaque. Together, they clear the lesions more effectively than alone.
Route of Administration
Topical
Onset Time
1 week
Duration
24 hours
Contraindications
Hypersensitivity to components, Calcium metabolism disorders, Viral or fungal skin infections
Information for Wynzora is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
